Star Health Insurance has announced strategic growth targets and operational improvements during its recent conference call, outlining plans to enhance profitability and operational efficiency in the coming quarters.

Growth and Return Targets

The health insurance company has set ambitious financial targets for the upcoming period. Management aims to achieve high teens growth while targeting mid to high teens return on equity, reflecting the company's focus on sustainable profitability and shareholder value creation.

Strategic Pricing Initiative

Star Health Insurance plans to implement comprehensive pricing updates across its business portfolio. The company intends to update pricing for 80% of its business by Q1, with management expecting these adjustments to contribute to improved earnings. This strategic pricing initiative represents a significant operational move aimed at optimizing the company's revenue structure.

Operational Improvements

Management has expressed confidence about ongoing improvements in the company's loss ratio, indicating positive trends in claims management and underwriting efficiency. The improved loss ratio suggests better risk assessment and claims processing, which are critical factors for profitability in the health insurance sector.

These strategic initiatives demonstrate Star Health Insurance's commitment to enhancing its market position through targeted pricing strategies and operational improvements, positioning the company for sustained growth in the competitive health insurance landscape.

Star Health and Allied Insurance Company Limited announced that its Board of Directors has approved an amended Policy on Insider Trading on April 28, 2026. The policy amendment was undertaken in compliance with Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Policy Overview and Compliance Framework

The amended policy serves as a comprehensive framework to prevent insider trading by regulating communication, procurement, and dealing in unpublished price sensitive information (UPSI). The policy functions as a Code of Conduct to regulate, monitor, and report trading by designated persons within the organization.

Key Policy Components

The policy encompasses three integral components that work together to ensure comprehensive compliance:

• Code of Practices and Procedures for Fair Disclosure of UPSI
• Policy and Procedures for Inquiry in case of Leak of UPSI or Suspected Leak of UPSI
• Trading regulations and pre-clearance mechanisms

Trading Window and Pre-clearance Requirements

The policy establishes specific trading windows during which designated persons may trade in the company's securities after securing pre-clearance. The trading window remains closed from the first day following each calendar quarter until 48 hours after disclosure of quarterly or annual financial results to stock exchanges.

Roles and Responsibilities

The policy clearly defines roles across different organizational levels. The Board of Directors specifies designated persons and ensures adequate internal control systems. The Chief Executive Officer/Managing Director implements effective compliance systems, while the Company Secretary serves as the Compliance Officer responsible for maintaining designated person lists, granting pre-clearance approvals, and monitoring trading activities.

Penalty Provisions and Enforcement

Violations of the policy result in structured penalties, with warning letters for first-time violations and monetary penalties up to 25% of transaction profits for subsequent violations. The Compliance Officer must inform stock exchanges of all policy violations within 48 hours. Penalty amounts collected are remitted to the SEBI Investors Education and Protection Fund.

The policy has been made available on the company's website at www.starhealth.in and will remain effective from the date of approval by the Board of Directors.